Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland

Edward Irvine, Ph.D
Postdoctoral Scientis at ETH Zürich, Sai Reddy Group
Speaker

Profile

Dr. Edward Irvine is a Postdoctoral Scientist at ETH Zurich in the laboratory of Prof. Sai Reddy, and will be starting his independent research group at the Benaroya Research Institute in Seattle in August. His research integrates immunology, protein engineering, and machine learning to develop novel platforms to predict and engineer immune function. Dr. Irvine completed his PhD at Harvard University, where he utilized computational immunology and antibody engineering strategies to investigate antibody-mediated control of Mycobacterium tuberculosis. His work has advanced our understanding of antibody Fc biology and how to program antibody function for therapeutic benefit.

Agenda Sessions

  • Generative Design of Antibody Fc-variants with Synthetic and Programmable Functional Profiles

    14:55